Rob van der Pluijm
Dr. Rob van der Pluijm is a Dutch clinician-scientist who has been working at the Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok since 2014.
Currently he coordinates the second phase of the Tracking Resistance to Artemisinin Collaboration project (TRAC II).
In addition he coordinates a trial on the safety, tolerability and efficacy of arterolane-piperaquine+mefloquine in Kenya.
Abstracts this author is presenting:
